Literature DB >> 1850961

Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction.

E L Khoury1, L Pereira, F S Greenspan.   

Abstract

Cytomegalovirus (CMV) infection of primary cultures established from human thyroid nodular and normal (paranodular) tissues resulted in induction of human leukocyte antigen (HLA) DR expression on thyroid follicular cells (TFC), as detected by cell-surface immunofluorescence staining with monoclonal antibodies (MAb). Two distinct modalities of induction were observed. The first type occurred in cultures of normal tissue obtained from CMV-seropositive but not seronegative donors, was detected on 30% to 50% of the TFCs, even though the vast majority of these cells failed to show any morphologic or antigenic evidence of individual CMV infection, and was associated with production of gamma-interferon (gamma-IFN) in vitro. The induced molecules displayed the characteristic DR polypeptide profile on immunoprecipitation and electrophoretic analysis. These results demonstrate that CMV infection of normal thyroid cultures may induce DR expression on TFCs in the absence of pre-existing lymphoid infiltrates and suggest that the induction is the result of an in vitro response to CMV by previously sensitized immunocompetent cells present in these primary cultures. Such a response, associated with the release of gamma-IFN, would induce DR expression on neighboring uninfected cells. The second mode of induction occurred in all CMV-infected cultures, regardless of their tissue origin (nodular or normal) or the serologic status of the donors. Up to 50% of infected TFCs at a late stage of infection, having fully developed CMV antigen-positive intranuclear inclusions, also displayed the cell-surface DR-related determinant recognized by one of the four anti-DR MAbs used. This induction was restricted to TFCs, while CMV-infected fibroblastoid cells present in the monolayers were invariably negative. Induction by CMV of major histocompatibility class II antigens on human epithelial cells may have significant implications in the development of normal immune responses against local viral infection, the enhancement of alloimmune rejection of grafted organs, and the generation of organ-specific autoimmune responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850961      PMCID: PMC1886009     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene.

Authors:  G W Kemble; A L McCormick; L Pereira; E S Mocarski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Virus-induced thyroiditis.

Authors:  J Srinivasappa; C Garzelli; T Onodera; U Ray; A L Notkins
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

4.  CMV infection, class II antigen expression, and human kidney allograft rejection.

Authors:  E von Willebrand; E Pettersson; J Ahonen; P Häyry
Journal:  Transplantation       Date:  1986-10       Impact factor: 4.939

5.  Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor.

Authors:  J E Grundy; J A McKeating; P J Ward; A R Sanderson; P D Griffiths
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

6.  Viral particles induce Ia antigen expression on astrocytes.

Authors:  P T Massa; R Dörries; V ter Meulen
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

7.  Selective induction of chromosomal gene expression by human cytomegalovirus.

Authors:  A M Colberg-Poley; L D Santomenna
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

8.  Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.

Authors:  W N Bartholomaeus; H O'Donoghue; D Foti; C M Lawson; G R Shellam; W D Reed
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

9.  Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes.

Authors:  J J Marchalonis; R E Cone; V Santer
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

10.  Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity.

Authors:  L K Borysiewicz; S Graham; J K Hickling; P D Mason; J G Sissons
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

View more
  10 in total

1.  Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease.

Authors:  Dimitrios Thomas; Feneli Karachaliou; Konstantina Kallergi; Elpis Vlachopapadopoulou; Georgia Antonaki; Fotini Chatzimarkou; Aspasia Fotinou; Philippos Kaldrymides; Stefanos Michalacos
Journal:  Endocrine       Date:  2008-05-13       Impact factor: 3.633

Review 2.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 3.  Molecular mimicry and autoimmune thyroid disease.

Authors:  Salvatore Benvenga; Fabrizio Guarneri
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

4.  Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells.

Authors:  D D Sedmak; A M Guglielmo; D A Knight; D J Birmingham; E H Huang; W J Waldman
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

5.  Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin 2 gene transcription.

Authors:  L J Geist; M M Monick; M F Stinski; G W Hunninghake
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis.

Authors:  Elisabetta Caselli; Maria Chiara Zatelli; Roberta Rizzo; Sabrina Benedetti; Debora Martorelli; Giorgio Trasforini; Enzo Cassai; Ettore C degli Uberti; Dario Di Luca; Riccardo Dolcetti
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

Review 7.  Immune disorders in Hashimoto's thyroiditis: what do we know so far?

Authors:  Aleksandra Pyzik; Ewelina Grywalska; Beata Matyjaszek-Matuszek; Jacek Roliński
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

Review 8.  Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6.

Authors:  Derek J Hanson; Joshua A Hill; David M Koelle
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

Review 9.  Possible role of human herpesvirus 6 as a trigger of autoimmune disease.

Authors:  Francesco Broccolo; Lisa Fusetti; Luca Ceccherini-Nelli
Journal:  ScientificWorldJournal       Date:  2013-10-24

10.  Autoimmune thyroid disorders.

Authors:  M A Iddah; B N Macharia
Journal:  ISRN Endocrinol       Date:  2013-06-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.